Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001096906-23-002003
Filing Date
2023-10-17
Accepted
2023-10-17 16:38:21
Documents
62
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 MYCOTOPIA THERAPIES, INC. - FORM 10-K/A SEC FILING tpia-20211231.htm   iXBRL 10-K/A 433166
  Complete submission text file 0001096906-23-002003.txt   2936948

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tpia-20211231_cal.xml EX-101.CAL 18575
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tpia-20211231_def.xml EX-101.DEF 76230
4 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT tpia-20211231_lab.xml EX-101.LAB 160133
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tpia-20211231_pre.xml EX-101.PRE 159197
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tpia-20211231.xsd EX-101.SCH 33879
56 EXTRACTED XBRL INSTANCE DOCUMENT tpia-20211231_htm.xml XML 390422
Mailing Address 480 22ND STREET HEYBURN ID 83336
Business Address 480 22ND STREET HEYBURN ID 83336 208-677-2020
Mycotopia Therapies, Inc. (Filer) CIK: 0001763329 (see all company filings)

EIN.: 870645794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-56022 | Film No.: 231329998
SIC: 2833 Medicinal Chemicals & Botanical Products